Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res Treat. 2012 Apr; 132(3):1049-62.

View in: PubMed

subject areas

Adult
Aged
Anthracyclines
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Breast Neoplasms
Clinical Trials as Topic
Disease-Free Survival
Female
Gene Expression Profiling
Humans
Kaplan-Meier Estimate
Middle Aged
Multicenter Studies as Topic
Multivariate Analysis
Neoadjuvant Therapy
Neoplasm Recurrence, Local
Neoplasm, Residual
Proportional Hazards Models
Receptors, Steroid
Taxoids
Trastuzumab

authors with profiles

Olufunmilayo Olopade